Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenaco
Bromfenac
Bromfenac sodium
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Bromfenacum
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Brand Names
Strenza Plus
Eugia-bromfenac
Xibrom
Bromday
Bromfenac Ophthalmic Solution
Pred-Brom
Bromsite 0.075%
Pred Phos - Brom
Apo-bromfenac
Yellox
Bromfenac 0.075%
Bromfenac Sodium
Bromfenac Ophthalmic Solution, 0.07%
Bromfenac
Pred-Gati-Brom
Prolensa
Auro-bromfenac
Bromfenac Ophthalmic Solution 0.09%
Pred Phos-Gati-Brom
Bromfenac Ophthalmic Solution, 0.09%
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682